Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
05/05/202014:59PR Newswire (US)Libtayo® (cemiplimab) Shows Clinically-Meaningful and Durable Responses in Second-line Advanced Basal Cell CarcinomaNASDAQ:REGNRegeneron Pharmaceuticals Inc
05/05/202006:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
29/04/202021:00PR Newswire (US)Regeneron Announces Upcoming Investor Conference PresentationsNASDAQ:REGNRegeneron Pharmaceuticals Inc
28/04/202001:12Dow Jones NewsCorrection to Drug Study Halted Early ArticleNASDAQ:REGNRegeneron Pharmaceuticals Inc
27/04/202021:29Dow Jones NewsDrug Study Halted Early for Certain Covid-19 Patients After No Benefit SeenNASDAQ:REGNRegeneron Pharmaceuticals Inc
27/04/202020:59PR Newswire (US)Phase 3 Trial of Libtayo® (cemiplimab) as Monotherapy for First-Line Advanced Non-small Cell Lung Cancer Stopped Early Due t...NASDAQ:REGNRegeneron Pharmaceuticals Inc
27/04/202020:58PR Newswire (US)Regeneron and Sanofi Provide Update on U.S. Phase 2/3 Adaptive-Designed Trial of Kevzara® (sarilumab) in Hospitalized COVID-...NASDAQ:REGNRegeneron Pharmaceuticals Inc
25/04/202006:09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
25/04/202006:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
21/04/202009:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
21/04/202009:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
21/04/202009:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
17/04/202006:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
17/04/202006:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
16/04/202022:14Dow Jones NewsRegeneron Gets FDA Priority Review for Ebola Virus TreatmentNASDAQ:REGNRegeneron Pharmaceuticals Inc
16/04/202021:00PR Newswire (US)FDA Accepts for Priority Review Biologics License Application for REGN-EB3 to Treat EbolaNASDAQ:REGNRegeneron Pharmaceuticals Inc
16/04/202006:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
14/04/202009:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
09/04/202006:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/04/202020:45Dow Jones NewsRegeneron, Zai Lab to Develop REGN1979 AntibodyNASDAQ:REGNRegeneron Pharmaceuticals Inc
08/04/202020:00GlobeNewswire Inc.Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/04/202020:00PR Newswire (US)Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/04/202020:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/04/202018:27Dow Jones NewsCorrection to Sanofi ArticleNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/04/202016:09Dow Jones NewsSanofi Finalizes Praulent Restructuring With RegeneronNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/04/202009:42Dow Jones NewsRegeneron Finalizes Praluent Agreement RestructuringNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/04/202007:00PR Newswire (US)Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting PresentationNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/04/202002:41Dow Jones NewsInside the Race to Find a Coronavirus CureNASDAQ:REGNRegeneron Pharmaceuticals Inc
04/04/202007:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
04/04/202007:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN

Your Recent History

Delayed Upgrade Clock